Physician profile
Anna D Walley
NPI 1528373586
$17,298.32
in general payments reported to CMS, 2019-2025
37 companies · $3,067 in 2025
The $3,067 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,373 · 2022: $2,372 · 2023: $4,956 · 2024: $4,529 · 2025: $3,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,410 · Travel and Lodging: $3,042 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,410.14 |
| Travel and Lodging | $3,041.85 |
| Education | $100.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $4,695.07 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $3,173.57 | 2021-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,433.66 | 2021-2025 | Airsupra, Breztri, Tezspire |
| Jazz Pharmaceuticals INC. | $979.52 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $912.13 | 2021-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $838.40 | 2021-2025 | Ofev, Jascayd, Spiriva Respimat |
| Genzyme Corporation | $665.25 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $626.99 | 2021-2025 | Uptravi, Opsumit, Opsynvi |
| Ani Pharmaceuticals, INC. | $474.97 | 2023-2025 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $471.14 | 2023-2025 | Sunosi |
| Mylan Specialty L.P. | $322.54 | 2022-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $308.95 | 2022-2025 | Dupixent |
| Insmed, INC. | $266.49 | 2021-2025 | Arikayce, Brinsupri |
| Takeda Pharmaceuticals U.S.A., INC. | $249.85 | 2021-2025 | Glassia |
| Janssen Pharmaceuticals, INC | $204.57 | 2021-2023 | Xarelto |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $177.20 | 2021-2025 | Tyvaso, Orenitram, Remodulin |
| Ibsa Pharma INC. | $176.86 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $170.29 | 2021-2023 | |
| Verona Pharma, INC. | $160.29 | 2025 | Ohtuvayre |
| Merck Sharp & Dohme LLC | $117.31 | 2021-2025 | Zerbaxa, Winrevair, Recarbrio |
| Baxter Healthcare | $113.21 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Harmony Biosciences LLC | $106.80 | 2022-2025 | Wakix |
| Genentech USA, INC. | $94.78 | 2021-2023 | Xolair |
| E.R. Squibb & Sons, L.L.C. | $84.12 | 2021-2023 | Eliquis |
| Avadel Cns Pharmaceuticals, LLC | $61.67 | 2025 | Lumryz |
| Electromed, INC. | $61.52 | 2024-2025 | Smartvest |
| Pfizer INC. | $59.20 | 2022-2025 | |
| Viatris Specialty LLC | $50.41 | 2025 | Yupelri |
| Advanced Respiratory, INC | $46.89 | 2021 | |
| Mayne Pharma Commercial LLC | $36.93 | 2021-2022 | |
| Philips North America LLC | $32.05 | 2021-2025 | Vest Therapy Und |
| Eisai INC. | $29.80 | 2021 | |
| Amgen INC. | $29.12 | 2023-2025 | Tezspire |
| Pulmonx Corporation | $19.77 | 2022 | |
| Itamar Medical INC | $17.58 | 2022 | |
| La Jolla Pharmaceutical Company | $16.10 | 2025 | Giapreza |
| Nabriva Therapeutics, Plc | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Walley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.